Home/Filings/4/0001193125-25-274204
4//SEC Filing

Weiss Amir 4

Accession 0001193125-25-274204

CIK 0000818686other

Filed

Nov 9, 7:00 PM ET

Accepted

Nov 10, 4:06 PM ET

Size

5.3 KB

Accession

0001193125-25-274204

Insider Transaction Report

Form 4
Period: 2025-11-06
Weiss Amir
Chief Accounting Officer
Transactions
  • Sale

    Ordinary Shares

    2025-11-06$24.44/sh12,300$300,56417,950 total
Footnotes (2)
  • [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.435 to $24.455, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.

Documents

1 file

Issuer

TEVA PHARMACEUTICAL INDUSTRIES LTD

CIK 0000818686

Entity typeother

Related Parties

1
  • filerCIK 0001897057

Filing Metadata

Form type
4
Filed
Nov 9, 7:00 PM ET
Accepted
Nov 10, 4:06 PM ET
Size
5.3 KB